Toggle Summary Aug 26, 2009
PRO-PHARMACEUTICALS TO PRESENT A CORPORATE UPDATE AT THE RODMAN & RENSHAW ANNUAL GLOBAL INVESTMENT CONFERENCE
View HTML
Toggle Summary Aug 24, 2009
Pro-Pharmaceuticals Appoints Arthur R. "Bobby" Greenberg to its Board of Directors
View HTML
Toggle Summary Aug 14, 2009
Pro-Pharmaceuticals Reports Second Quarter and First Six Months 2009 Financial Results
View HTML
Toggle Summary Jul 23, 2009
COURT ISSUES JUDGMENT DISMISSING TRADE SECRET LAWSUIT AGAINST PRO-PHARMACEUTICALS
View HTML
Toggle Summary Jul 17, 2009
PRO-PHARMACEUTICALS PREVAILS IN TRADE SECRET LAWSUIT
Court Dismisses Claims For Lack of Prosecution
View HTML
Toggle Summary Jul 14, 2009
PRO-PHARMACEUTICALS NAMES NOTED PHYSICIAN DR. GILBERT S. OMENN TO SCIENTIFIC ADVISORY BOARD
Professor of Internal Medicine, Human Genetics and Public Health at the University of Michigan. Former CEO of the University of Michigan Health System.
View HTML
Toggle Summary Jul 06, 2009
PRO-PHARMACEUTICALS CLOSES $500,000 TRANCHE; BRINGS TOTAL TO $3.2 MILLION OF $6.0 MILLION PRIVATE PLACEMENT
View HTML
Toggle Summary Jun 24, 2009
PRO-PHARMACEUTICALS' CHIEF SCIENTIST PUBLISHED ARTICLES IN THREE PRESTIGIOUS PEER-REVIEWED JOURNALS
NMR Studies Further Define DAVANAT®'s Mechanism of Action with Galectin Receptors Found on Solid Tumors
View HTML
Toggle Summary May 30, 2009
PRO-PHARMACEUTICALS REPORTS FULL YEAR and FOURTH QUARTER 2008 FINANCIAL RESULTS
View HTML
Toggle Summary May 15, 2009
Pro-Pharmaceuticals Reports First Quarter 2009 Financial Results
View HTML